| Code | Description | Claims | Beneficiaries | Total Paid |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12,209 |
7,079 |
$532K |
| 80053 |
Comprehensive metabolic panel |
16,709 |
14,595 |
$378K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,721 |
9,157 |
$230K |
| 88307 |
|
2,609 |
2,362 |
$230K |
| 80061 |
Lipid panel |
9,802 |
9,313 |
$172K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
3,640 |
3,491 |
$134K |
| 88342 |
|
2,061 |
1,514 |
$126K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
3,575 |
3,374 |
$122K |
| 80050 |
General health panel |
1,685 |
1,590 |
$115K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,941 |
1,860 |
$110K |
| 36415 |
Collection of venous blood by venipuncture |
39,946 |
34,424 |
$101K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,596 |
10,211 |
$96K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,292 |
10,201 |
$86K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
8,604 |
8,195 |
$85K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,329 |
2,204 |
$83K |
| 86803 |
|
3,477 |
3,283 |
$72K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
820 |
789 |
$69K |
| 86850 |
|
3,626 |
3,386 |
$68K |
| 87150 |
|
1,811 |
1,701 |
$65K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,008 |
3,457 |
$57K |
| 82728 |
|
4,042 |
3,819 |
$55K |
| 82607 |
|
2,417 |
2,265 |
$54K |
| 88141 |
|
1,534 |
1,482 |
$51K |
| 86780 |
|
4,207 |
4,011 |
$50K |
| 87077 |
|
3,437 |
3,071 |
$49K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
903 |
871 |
$45K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
894 |
861 |
$43K |
| 87186 |
|
4,141 |
3,705 |
$39K |
| 84439 |
|
5,593 |
5,268 |
$36K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
405 |
372 |
$34K |
| 87070 |
|
2,518 |
2,300 |
$32K |
| 83970 |
|
514 |
476 |
$31K |
| 81001 |
|
9,575 |
7,170 |
$30K |
| 83550 |
|
4,198 |
3,950 |
$29K |
| 80074 |
|
365 |
357 |
$27K |
| 88304 |
|
2,038 |
1,756 |
$27K |
| 87390 |
|
1,282 |
1,252 |
$26K |
| 87340 |
|
2,807 |
2,654 |
$26K |
| 86140 |
|
4,848 |
4,370 |
$25K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
214 |
199 |
$24K |
| 0240U |
|
134 |
129 |
$23K |
| 85027 |
|
3,414 |
3,152 |
$22K |
| 88341 |
|
302 |
193 |
$22K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
150 |
149 |
$22K |
| 87631 |
|
184 |
165 |
$21K |
| 82570 |
|
4,454 |
4,056 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
220 |
213 |
$20K |
| 83540 |
|
4,314 |
4,042 |
$20K |
| 84702 |
|
1,570 |
1,161 |
$20K |
| 85610 |
|
3,629 |
2,513 |
$19K |
| 84165 |
|
1,250 |
885 |
$17K |
| 86762 |
|
662 |
633 |
$17K |
| 84146 |
|
739 |
673 |
$16K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
419 |
404 |
$16K |
| 82043 |
|
2,597 |
2,481 |
$16K |
| 87210 |
|
2,295 |
2,131 |
$14K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
285 |
273 |
$14K |
| 84153 |
|
273 |
264 |
$13K |
| 88112 |
|
297 |
241 |
$12K |
| 87147 |
|
1,257 |
1,116 |
$12K |
| 83735 |
|
1,766 |
1,320 |
$11K |
| 84403 |
|
355 |
306 |
$11K |
| 87522 |
Neg quan hep c or qual rna |
175 |
163 |
$11K |
| 80069 |
|
899 |
784 |
$10K |
| 87634 |
|
154 |
147 |
$9K |
| 88312 |
|
151 |
83 |
$9K |
| 80076 |
|
711 |
637 |
$8K |
| 87205 |
|
2,306 |
2,121 |
$8K |
| 82746 |
|
443 |
425 |
$7K |
| 81003 |
|
3,229 |
2,773 |
$7K |
| 83001 |
|
389 |
340 |
$7K |
| 86706 |
|
545 |
496 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
385 |
363 |
$6K |
| 86900 |
|
2,110 |
1,935 |
$6K |
| 82950 |
|
1,198 |
1,146 |
$6K |
| 86901 |
|
2,006 |
1,853 |
$6K |
| 86038 |
|
250 |
241 |
$6K |
| 85652 |
|
2,517 |
2,279 |
$6K |
| 83880 |
|
145 |
126 |
$5K |
| 84156 |
|
1,592 |
1,376 |
$5K |
| 84481 |
|
245 |
230 |
$5K |
| 86696 |
|
65 |
64 |
$4K |
| 83690 |
|
573 |
527 |
$4K |
| 82670 |
|
173 |
137 |
$4K |
| 86704 |
|
351 |
316 |
$4K |
| 85060 |
|
125 |
117 |
$3K |
| 82565 |
|
527 |
499 |
$3K |
| 86702 |
|
1,302 |
1,269 |
$3K |
| 83516 |
|
120 |
116 |
$3K |
| 86334 |
|
206 |
162 |
$3K |
| 88311 |
|
398 |
362 |
$3K |
| 81015 |
|
797 |
759 |
$3K |
| 84100 |
|
476 |
318 |
$2K |
| 86701 |
|
1,282 |
1,250 |
$2K |
| 82550 |
|
263 |
238 |
$2K |
| 86431 |
|
292 |
272 |
$2K |
| 87279 |
|
112 |
37 |
$2K |
| 82077 |
|
68 |
65 |
$2K |
| 81025 |
|
131 |
123 |
$2K |
| 88302 |
|
137 |
112 |
$1K |
| 85730 |
|
303 |
288 |
$1K |
| 83002 |
|
81 |
69 |
$1K |
| 87641 |
|
17 |
16 |
$1K |
| 82533 |
|
62 |
60 |
$1K |
| 84550 |
|
224 |
203 |
$1K |
| 85018 |
|
604 |
593 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
46 |
46 |
$1K |
| 86480 |
|
12 |
12 |
$1K |
| 87046 |
|
17 |
17 |
$1K |
| 82140 |
|
55 |
51 |
$944.60 |
| 82247 |
|
165 |
96 |
$776.16 |
| 88142 |
|
18 |
18 |
$653.06 |
| 85379 |
|
56 |
53 |
$647.24 |
| 82784 |
|
48 |
37 |
$622.14 |
| 86695 |
|
63 |
63 |
$609.85 |
| 87299 |
|
38 |
37 |
$579.60 |
| 87276 |
|
38 |
37 |
$578.52 |
| 82105 |
|
40 |
36 |
$554.62 |
| 87280 |
|
38 |
37 |
$532.80 |
| 87260 |
|
38 |
37 |
$532.80 |
| 87275 |
|
38 |
37 |
$532.80 |
| 87493 |
|
13 |
12 |
$484.53 |
| 87653 |
|
16 |
12 |
$476.63 |
| 86300 |
|
28 |
24 |
$474.50 |
| 36416 |
|
67 |
64 |
$439.20 |
| 86364 |
|
15 |
12 |
$397.90 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
732 |
559 |
$381.83 |
| 82378 |
|
15 |
12 |
$303.36 |
| 82248 |
|
69 |
51 |
$286.31 |
| 84144 |
|
14 |
12 |
$219.03 |
| 83615 |
|
28 |
27 |
$205.36 |
| 80164 |
|
17 |
13 |
$176.02 |
| 82947 |
|
50 |
50 |
$148.29 |
| 87328 |
|
14 |
14 |
$147.00 |
| 86200 |
|
12 |
12 |
$116.12 |
| 84703 |
|
12 |
12 |
$104.47 |
| 82150 |
|
13 |
13 |
$100.44 |
| 87427 |
|
18 |
18 |
$95.84 |
| 87329 |
|
14 |
14 |
$71.88 |
| 87045 |
|
17 |
17 |
$66.08 |
| 84460 |
|
14 |
14 |
$42.40 |
| 84450 |
|
13 |
13 |
$41.44 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
97 |
96 |
$0.00 |